Document ID: FDA-2008-N-0043-0016
Agency: fda
Document Type: Notice
Title: Memorandum of Understanding Between the Office of the Assistant Secretary of Defense (Health Affairs), the Veterans Health Administration, and the U.S. Food and Drug Administration
Posted Date: 2008-12-17T05:00Z

[Federal Register: December 17, 2008 (Volume 73, Number 243)]
[Notices]               
[Page 76658-76668]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr17de08-91]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2008-N-0043]
[FDA No. 225-08-8003]

 
Memorandum of Understanding Between the Office of the Assistant 
Secretary of Defense (Health Affairs), the Veterans Health 
Administration, and the U.S. Food and Drug Administration

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
a memorandum of understanding (MOU) between the Office of the Assistant 
Secretary of Defense (Health Affairs), the Veterans Health 
Administration, and the U.S. Food and Drug Administration. The purpose 
of the MOU is to enhance knowledge and efficiency by providing for the 
sharing of information and expertise between the Federal partners. The 
goals of the collaboration are to explore ways to: Further enhance 
information sharing efforts through more efficient and robust 
interagency activities; promote efficient utilization of tools and 
expertise for product risk identification, validation and analysis; and 
build infrastructure and processes that meet the common needs for 
evaluating the safety, efficacy, and utilization of drugs, biologics, 
and medical devices, as well as the safety and utilization of foods. 
The MOU is available on FDA's Web site at www.fda.gov/oc/mous/domestic/
domesticmous.htm.

DATES: The agreement became effective November 25, 2008.

FOR FURTHER INFORMATION CONTACT: Erik Mettler, Office of Policy, Food 
and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, rm. 4324, 
Silver Spring, MD 20993, 301-796-4830.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which 
states that all written agreements and MOUs between FDA and others 
shall be published in the Federal Register, the agency is publishing 
notice of this MOU.

    Dated: December 11, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.

[[Page 76659]]

[GRAPHIC] [TIFF OMITTED] TN17DE08.000

[[Page 76660]]

[GRAPHIC] [TIFF OMITTED] TN17DE08.001

[[Page 76661]]

[GRAPHIC] [TIFF OMITTED] TN17DE08.002

[[Page 76662]]

[GRAPHIC] [TIFF OMITTED] TN17DE08.003

[[Page 76663]]

[GRAPHIC] [TIFF OMITTED] TN17DE08.004

[[Page 76664]]

[GRAPHIC] [TIFF OMITTED] TN17DE08.005

[[Page 76665]]

[GRAPHIC] [TIFF OMITTED] TN17DE08.006

[[Page 76666]]

[GRAPHIC] [TIFF OMITTED] TN17DE08.007

[[Page 76667]]

[GRAPHIC] [TIFF OMITTED] TN17DE08.008

[[Page 76668]]

[FR Doc. E8-29952 Filed 12-16-08; 8:45 am]

BILLING CODE 4160-01-S